Modulation of the unfolded protein response by the human hepatitis B virus by Catalin Lazar et al.
REVIEW ARTICLE
published: 19 August 2014
doi: 10.3389/fmicb.2014.00433
Modulation of the unfolded protein response by the human
hepatitis B virus
Catalin Lazar , Mihaela Uta and Norica Branza-Nichita*
Department of Viral Glycoproteins, Institute of Biochemistry of the Romanian Academy, Bucharest, Romania
Edited by:
Shiu-Wan Chan, The University of
Manchester, UK
Reviewed by:
Chiaho Shih, Academia Sinica,
Taiwan
Shiu-Wan Chan, The University of
Manchester, UK
*Correspondence:
Norica Branza-Nichita, Department
of Viral Glycoproteins, Institute of
Biochemistry of the Romanian
Academy, Splaiul Independentei
296, Sector 6, Bucharest 060031,
Romania
e-mail: nichita@biochim.ro;
norica70@yahoo.co.uk
During productive viral infection the host cell is confronted with synthesis of a vast
amount of viral proteins which must be folded, quality controlled, assembled and secreted,
perturbing the normal function of the endoplasmic reticulum (ER). To counteract the ER
stress, cells activate specific signaling pathways, designated as the unfolded proteins
response (UPR), which essentially increase their folding capacity, arrest protein translation,
and degrade the excess of misfolded proteins. This cellular defense mechanism
may, in turn, affect significantly the virus life-cycle. This review highlights the current
understanding of the mechanisms of the ER stress activation by Human Hepatitis B
virus (HBV), a deadly pathogen affecting more than 350 million people worldwide. Further
discussion addresses the latest discoveries regarding the adaptive strategies developed
by HBV to manipulate the UPR for its own benefits, the controversies in the field and
future perspectives.
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INTRODUCTION
An important amount of experimental data accumulated in
the last decade have not only demonstrated that viruses can
induce endoplasmic reticulum (ER) stress in mammalian cells,
but importantly, that the cellular response to this stress may play a
crucial part in the evolution of the disease (Netherton et al., 2004;
Tardif et al., 2005). This is not surprising, since an infected cell
must manage a vast quantity of viral proteins that are synthesized
over a short period of time during productive infection, often
leading to perturbation of the ER homeostasis, proteinmisfolding
and aggregation.
Discovered more than 40 years ago, with an efficient vaccine
developed against it, the Human Hepatitis B virus (HBV) infec-
tion is still a frequent viral disease and a major cause of chronic
liver pathogenesis. About 350 million people are currently HBV
carriers worldwide and at high risk to develop hepatocellular
carcinoma (HCC), the third leading cause of cancer death in
humans. Despite decades of intensive research and comprehen-
sive investigations at large scale, such as by using proteomics and
transcriptomics technologies, the HBV interactions with the host
cells and the molecular mechanisms underlying the viral patho-
genesis and progression are not clearly understood. The lack of
an efficient and robust in vitro infectivity model has been a major
drawback, preventing in depth studies in a natural infection sys-
tem (Gripon et al., 2002). However, HBV is one of the few viruses
Abbreviations: Akt, protein kinase B; Atg, autophagy-related; BiP, immunoglobu-
lin heavy chain binding protein; GGH, ground glass hepatocytes; GRP78, glucose-
regulated protein of 78 kDa; GRP94, glucose-regulated protein of 94 kDa; LC3,
microtubule-associated light chain 3; 3-MA, 3-methyladenine; mTOR,mammalian
target of rapamycin; NF-kB, nuclear factor kB; PI3KC3, class III phosphatidyli-
nositol 3-kinase; V-ATPase, vacuolar ATPase; VEGF-A, vascular endothelial growth
factor A.
demonstrated to induce ER stress, with strong support by in vivo
data.
HBV is the representative of the Hepadnaviridae family of
DNA viruses. Its genome consists of a partially double-stranded
DNA molecule of 3.2 kb encoding the envelope (surface) pro-
teins, a core protein, the reverse transcriptase and the regulatory
X protein (HBx), within four overlapping open reading frames
(ORF) (Schadler and Hildt, 2009). The surface proteins, namely
the large (L), middle (M), and small (S) are synthesized from
three different initiation codons within the same ORF and share
the tetra-spanning transmembrane S domain. In addition to S,
the M and L proteins contain the preS2 and the preS1-preS2
regions, respectively at their N-terminal end (Figure 1A). The
surface proteins are co-translationally inserted into the ER mem-
brane, fold and oligomerize by extensive disulfide bonding, before
being transported to the budding sites for assembly into virions
and non-infectious subviral particles (SVP) (Chai et al., 2008).
The preS1 domain adopts a dual topology at the ER membrane
enabling the interaction of the L protein with both, the core
protein in the cytoplasm and the viral receptors at the plasma
membrane (Lambert and Prange, 2001). Due to this intriguing
feature, the L protein is indispensable to HBV assembly and entry
into hepatocytes, but not to SVP formation. Interestingly, when
expressed alone, the L protein assembles into particles that are
retained within the ER lumen. Secretion of the L protein is res-
cued when eitherM and/or S proteins are co-expressed and incor-
porated into these particles (Bruss and Ganem, 1991). Similarly,
excessive production of L, overM and S, results in retention of
all three proteins and oligomers as well as virions, demonstrating
that the ratio between the surface proteins plays a crucial role in
the HBV life-cycle (Chisari et al., 1986). Therefore, it is not sur-
prising that expression of the surface proteins is tightly regulated
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FIGURE 1 | Schematic representation of the HBV surface proteins. The asterisk shows the location of the major mutations identified in patients with
ground glass hepatocytes (A). Signaling pathways activated in ground glass hepatocytes, with potential role in carcinogenesis (B).
by different promoters, namely, the preS1 promoter, which con-
trols the L transcript and the S promoter regulating transcription
of theM and S mRNAs. This control results in differential expres-
sion of the surface proteins, S being the most abundant of them,
whileM and L are expressed at much lower levels of about 5–15%
and 1–2%, respectively (Yokosuka and Arai, 2006).
HBV INDUCES ER STRESS
The first indication of the ER stress and the intracellular morpho-
logical modification induced by HBV infection came more than
40 years ago, from studies of cirrhotic and carcinomas liver biop-
sies, showing a strong hypertrophy of the ER within hepatocytes.
Initially associated with a disregulated glycogen metabolism, the
presence of the altered subcellular structures was later clearly
related to the expression of HBV surface proteins (Hadziyannis
et al., 1973). Due to their microscopic appearance, these cells were
termed “ground glass hepatocyte” (GGH) and their detection
became an important parameter in the diagnostic of HBV-related
pathogenesis (Pópper, 1975). The phenotype was classified in
type I, characterized by a random distribution of the GGH in the
hepatic tissue, and type II, where larger regions of clustered GGH
are observed, occurring usually at later stages of infection (Fan
et al., 2000, 2001). A potential mechanism of this unusual intra-
cellular accumulation of the secretory proteins was suggested with
the discovery that mutations in the pre-S1 domain of the L pro-
tein inhibited secretion of the surface proteins, inducing the GGH
phenotype (Xu and Yen, 1996). Moreover, a deletion naturally
occurring in the pre-S2 region of the same protein produced sim-
ilar effects, suggesting that mutations in the entire pre-S region
are responsible for the accumulation of the viral proteins and the
development of the GGH morphology (Fan et al., 2000, 2001).
The level of this accumulation appears to play a crucial role in
triggering the ER stress since natural pre-S2 deletion leading to a
moderate retention of the HBV envelope proteins were not able
to induce cellular toxicity, at least in vitro (Tai et al., 2002).
The ability of secretion-incompetent pre-S mutants to specif-
ically activate ER stress signaling pathways in host cells was
further demonstrated by the up-regulation of well-established
stress sensors such as GRP78 (BiP), GRP94, and ER-resident
kinases (Wang et al., 2003). These stress signals could also induce
oxidative DNA lesions and mutagenesis (Chen et al., 2006; Hsieh
et al., 2007), caspase 12-mediated apoptosis, or NF-kB-mediated
cell proliferation with an important role in cancer develop-
ment (Qu et al., 2004). Interestingly, the Akt/mTOR pathway
and the VEGF-A synthesis were found significantly activated in
GGHs (Yang et al., 2009); it is therefore tempting to speculate
that the ER stress induced by the pre-S mutants plays a key
role in progression of HBV pathogenesis, leading to neoplastic
lesions of the liver in chronically infected patients. The obser-
vation that the cell-cycle progression is directly affected by the
ER stress provides additional data in support of this hypothe-
sis. The ER accumulation of a pre-S2 mutant protein promotes
cyclin A cleavage by the calcium-dependent protease μ-calpain,
followed by its translocation from the nucleus into the cytoplasm
and centrosome overduplication (Wang et al., 2012). The cyto-
plasmic distribution of cyclin A reported in transgenic mouse
livers expressing pre-S2 mutants appears to favor this mecha-
nism (Wang et al., 2005) (Figure 1B). However, these results must
be interpreted with care, as overexpression of the wild-type L
protein in transgenic mice was shown to be sufficient to induce
aberrant changes in the hepatocyte, “ground-glass” appearance,
cell death and nodular hyperplasia of the liver (Chisari et al.,
1987).
Interestingly, a point L77Rmutation occurring naturally in the
cytosolic loop of the S protein results in retention of the S protein
in the ER-Golgi compartment, probably due to impaired folding
(Chua et al., 2005). Despite of this significant accumulation, no
ER stress was detected in cells expressing this mutant variant, rais-
ing the question whether the pre-S-independent accumulation of
the envelope proteins is able to induce UPR signaling.
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REGULATORY MECHANISMS ACTIVATED IN HBV-INFECTED
CELLS TO REDUCE THE ER STRESS
To alleviate the ER stress, cells initiate a complex signaling cas-
cade termed the unfolded protein response (UPR), which relies
on activation of three complex signaling pathways at the ER level
and continued in the cell nucleus. The sensors of the ER stress
and the key regulators of these pathways are the transmembrane
proteins inositol-requiring protein 1 (IRE1) α and β, the activat-
ing transcription factor 6 (ATF6) α and β and the protein kinase
RNA-like ER kinase (PERK), all regulated by BiP. Binding of these
sensors to BiP maintains them in an inactive state; this process is
competed by the accumulation of unfolded proteins within the
ER, which also require interaction with BiP to prevent termi-
nal misfolding and aggregation. Eventually BiP is released from
the interaction with IRE1, ATF6, and PERK (Kimata et al., 2004)
which promotes their activation by dimerization and autophos-
phorylation (PERK and IRE1) (Liu et al., 2000; Su et al., 2008)
or by trafficking to the Golgi apparatus and further proteolytic
processing (ATF6) (Ye et al., 2000; Chen et al., 2002). Activated
IRE1 directs splicing of the full-length (unspliced) XBP1 mRNA
(XBP1u) generating a shorter variant. This encodes a highly active
transcription factor (XBP1s) which is able to induce transcrip-
tion of selected genes by binding the ER stress response elements
(ERSE) containing the consensus sequence CCAAT-N9-CCACG
(Yoshida et al., 1998, 2001; Lee et al., 2002). Activated PERK phos-
phorylates the α subunit of the eukaryotic initiation factor-2 α
(eIF2α), blocking the assembly of the ribosomal complex and thus
protein translation (Ma et al., 2002). ATF6 cleavage within the
Golgi releases its N-terminal domain which translocates to the
nucleus and functions as a transcription factor on target genes,
including that encoding for XBP1 (Haze et al., 1999). Collectively,
these complex transcriptional activities and cross-talks between
the signaling pathways result in: (a) attenuated protein trans-
lation (b) increased transcription of ER chaperone genes; (c)
up-regulation of key molecules of the ER degradation machinery.
Interestingly, a first regulatory mechanism involved in alle-
viation of the ER stress produced by HBV infection was first
described at viral level. It was observed that overexpression of the
L protein increased the transcriptional activity of the S promoter
by up to 10 folds, while neither M, S, or a secreted variant of L
had a similar effect (Xu et al., 1997). Moreover, L accumulation
also activated the promoters of the genes encoding for GRP78
and GRP94, the two chaperone proteins up-regulated during ER
stress (Ramakrishnan et al., 1995; Roy and Lee, 1995). Activation
of these promoters by the L protein was shown to depend on the
transcription nuclear factor NF-Y and its binding to the CCAAT
element, also present in the S promoter. Two cis-acting elements
in the S promoter, namely Z1 and Z2 flanking the CCAAT region
were also required for its activation by the ER stress, through
a, yet unknown, transcription factor called “Z.” The activation
of the S promoter was later shown to be independent of the
PERK pathways (Huang et al., 2005); rather, expression of the “Z”
factor was induced by XBP1(s) the transcription factor resulted
following IRE1 activation (Calfon et al., 2002). Since XBP1(s)
and ATF6-alpha interact with each other to form heterodimers
and bind to similar DNA sequences (Lee et al., 2002), a poten-
tial involvement of the ATF6-alpha pathway in this regulation,
although not directly demonstrated, could not be excluded in this
study.
An interesting hypothesis emerging from this investigation was
based on the observation that induction of the “Z” factor by the
ER stress was restricted to certain cell types, including liver and
kidney cells, but not fibroblasts. Given the ubiquity of the UPR
signaling pathways, this result is rather unusual and may indicate
that the cells have also evolved specific mechanisms in response
to ER stress stimuli that are characteristic to a specific tissue.
HBx and S proteins were also shown to activate the IRE1/XBP1
branch of the UPR, in independent studies. The HBx protein
expressed transiently in Hep3B and HepG2 cells resulted in a
significant increase of the XBP1 promoter activity, by up to 7
folds, as demonstrated using a luciferase expression reporter (Li
et al., 2007). Moreover, splicing of the Xbp-1 mRNA occurred
efficiently in these cells, and the presence of XBP1(s) was clearly
evidenced in the same study. Splicing of the Xbp-1 mRNA was
also shown in HepG2.2.2.15 cells, which contain two copies
of the HBV genome and support HBV replication, assembly
and secretion of SVPs and of fully infectious virions. The pro-
cess depended on the HBx expression level, further supporting
the involvement of this protein in UPR activation (Li et al.,
2007). Similarly, Huh7 hepatoma cells overexpressing the S pro-
tein contained both, the precursor and the spliced form of the
Xbp-1 mRNA, suggesting that the envelope protein is also able
to trigger UPR via the IRE1/XBP1 pathway (Li et al., 2011).
However, whether or not XBP1-specific target genes were actu-
ally activated in these systems had not been investigated in either
study.
ACTIVATION OF THE ER-ASSOCIATED DEGRADATION (ERAD)
BY HBV
The first UPR target demonstrated to depend entirely on the
IRE1-XBP1 pathway was the gene encoding for a member of the
ER degradation-enhancing, mannosidase-like family of proteins
(EDEM1) (Yoshida et al., 2003). EDEM1 and its two homologs
EDEM2 (Mast et al., 2005) and EDEM3 (Hirao et al., 2006)
belong to the glycoside hydrolase 47 family and are believed to
play an important role in alleviating the ER stress during UPR, by
targetingmisfolded glycoproteins to ERAD (Olivari andMolinari,
2007).
Our investigation on the ERAD function in the HBV life-cycle
revealed strong evidence that HBV and the IRE1-XBP1 branch
of the UPR are in tight, mutual relationship. Synthesis of the
transcripts encoding for the three members of the EDEM fam-
ily was significantly increased in HepG2.2.215 cells hosting stable
HBV replication, or Huh7 cells replicating the virus in a transient
manner (Lazar et al., 2012). Moreover, while HepG2 cells express
only trace amounts of EDEM1, expression of this protein became
clearly detectable in HepG2.2.215 cells. It is important to note
that activation of EDEM synthesis was not related to HBV replica-
tion and nucleocapsids accumulation within cells, as it occurred
with similar efficiency in the presence of lamivudine, a strong
DNA replication inhibitor (Doong et al., 1991). Rather, over-
expression of the surface proteins appeared sufficient to induce
EDEM up-regulation, which is in agreement with the ability of
these proteins to activate the IRE1/XBP1 branch of the UPR (Li
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et al., 2011). EDEM1 overproduction induced a significant degra-
dation of the wild-type S, M, and L proteins, when expressed
either independently, or in the context of a full replication-cycle.
This observation was surprising, since EDEM has been tradition-
ally involved in disposal of misfolded proteins and therefore, it
called for a deeper investigation.
The incapacity of the ER folding machinery to deal with an
excess of viral protein synthesis could be a possible explanation
for this result. However, silencing of the endogenous EDEM1
resulted in intracellular accumulation of the HBV surface pro-
teins, accompanied by a significant increase of their secretion.
This strongly suggests that an important fraction of folding-,
assembly-, and secretion-competent envelope proteins is deliv-
ered to degradation during HBV protein synthesis. Interestingly,
the proteins rescued from degradation in EDEM1 knocked-down
cells were recruited for nucleocapsid envelopment, increasing
the amount of secreted virions. Thus, despite the availability of
correctly folded surface proteins, their trafficking to the corre-
sponding virus particles and SVP budding sites appear to be
competing, rather than successive processes.
In search for a mechanism of action underlying the effects of
EDEM1 modulation on the HBV life-cycle, a direct interaction
between the endogenous protein and the viral polypeptides was
evidenced by co-immunoprecipitation. EDEM1 co-precipitated
both, the glycosylated and non-glycosylated isoforms of the enve-
lope proteins. Moreover, investigation of the surface proteins
oligomerization in EDEM1-depleted cells showed that EDEM1
acts early during surface protein synthesis, most probably before
their assembly into oligomers. Collectively, these experiments
point to an N-glycan-independent mechanism of EDEM1 bind-
ing to the viral substrates, possibly involving the common
S-domain. These data are in support of a more recent model
of EDEM1-substrate recognition, implying a glycan-independent
binding of the ERAD targets (Cormier et al., 2009). The evidence
of EDEM1 interaction with wild-type proteins and the obser-
vation that glycoprotein substrates are still targeted to ERAD in
the absence of mannose trimming, when EDEM1 is up-regulated
(Ron et al., 2011), have added new angles to this model. It was
proposed that the significant induction of EDEM1 expression
in HBV-replicating cells promotes extraction of conformation-
viable viral polypeptides from the ER-resident protein quality
control cycle and their premature delivery to degradation (Lazar
et al., 2012). This has important consequences on the HBV life-
cycle (summarized in Figure 2), resulting in reduction of SVP and
virion production.
The concept that wild-type proteins can also be degraded
during UPR is supported by data obtained from studies on
Human Hepatitis C virus (HCV), showing a direct involvement
of EDEM1 in regulating the production of wild-type envelope
proteins at post-translational level (Saeed et al., 2011). EDEM1
overexpression promotes degradation of the E1 and E2 surface
proteins, which results in down-regulation of HCV particles pro-
duction. Conversely, the E2 protein shows greater stability in
EDEM1 knocked-down cells, which also produce an increased
amount of infectious HCV, with no effect on viral replication
(Saeed et al., 2011).
An important question arising from these investigations
regards the validity of this concept for the UPR induced during
conditions other than viral infections. Most of the pioneering
works leading to characterization of the UPR signaling path-
ways have usedmodel proteins undergoing severe conformational
changes, due to genetic mutations or other environmental fac-
tors, often leading to pathogenesis. These conditions are known
as “folding diseases,” of which some neurodegenerative disorders,
FIGURE 2 | HBV interaction with the ER-associated degradation
pathway. HBV activates expression of EDEMs, which promote degradation
of wild-type, assembly-competent HBV surface proteins, reducing the
production of subviral and viral particles (A). Silencing of endogenous EDEM1
in HBV replicating cells induces accumulation of folding-competent envelope
proteins and increases secretion of subviral and viral particles (B).
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diabetes, obstructive pulmonary disease are best documented
(Yoshida, 2007). It would be interesting to extend this research to
other wild-type cellular proteins to understand the subtleties of
the molecular discrimination between correctly folded and mis-
folded proteins and their degradation and identify the cellular
factors involved in this recognition.
Unlike the case of “folding diseases,” the amount of data
regarding the UPR in viral infections is relatively limited and con-
troversial; in addition to HBV and HCV discussed above, only
a few other viruses, such as Borna Disease Virus (Williams and
Lipkin, 2006), murine leukemia virus (Dimcheff et al., 2006),
rotaviruses (Trujillo-Alonso et al., 2011), or the West Nile virus
(Ambrose and Mackenzie, 2011) have been reported to induce
ER stress. Most of these viruses have adapted mechanisms to use
the UPR signaling pathways to their own benefit, whether this is
assistance for proper protein folding or replication. In the case
of the HBV/HCV, it is tempting to speculate that activation of
the ERAD pathway would limit the amount of surface proteins
available for nucleocapsid envelopment, on one hand, and avoid
extensive damage of the ER due to viral protein accumulation, on
the other hand, thus enabling the evolution of infection toward
chronicity.
HBV INDUCES AUTOPHAGY
It has been established that prolonged UPR eventually leads
to cells death by apoptosis. However, before making the ulti-
mate choice, cells under severe ER stress are able to recruit
survival pathways, such as autophagy. Autophagy is a catabolic
process, highly conserved during evolution, involving degrada-
tion of long-livedmacromolecules and defective organelles within
double membrane compartments, called autophagosomes (He
and Klionsky, 2009). Interestingly, several viruses, including HBV,
were shown to induce autophagy and further exploit it in pro-
ductive or unproductive infections (Pratt and Sugden, 2012).
Activation of autophagy by HBV has been clearly demonstrated
by two independent groups (Sir et al., 2010; Li et al., 2011),
leading to one of the most interesting, recent controversy in the
HBV field (Figure 3). Both groups have observed conversion of
the autophagic marker LC3 from the cytosolic to the lipidated,
autophagosome-associated form in HBV transfected cells (Sir
et al., 2010; Li et al., 2011) and livers of HBV-infected patients or
transgenic mice (Sir et al., 2010). Autophagosomes formation in
the presence of HBV was also convincingly confirmed by electron
and confocal microscopy; notably, this was not accompanied by
protein degradation, suggesting a strong interference of HBVwith
the autophagy signaling pathway preventing further clearance of
the engulfed macromolecules (Sir et al., 2010; Li et al., 2011).
However the two studies diverge in their proposedmechanisms of
HBV-induced autophagy and the interpretation of the role played
by this process at different steps of the viral life-cycle. A first indi-
cation of a viral factor involvement in autophagy induction was
reported by Tang and collaborators (Tang et al., 2009). It was
shown that Beclin-1 expression in hepatic and hepatoma cells was
modulated by HBx, which acts at transcriptional level, activating
FIGURE 3 | Signaling pathways modulated by HBV for its own
benefit. The surface proteins activate the UPR leading to autophagy,
involved in nucleocapsid envelopment and virus particle secretion.
Activation of the IRE1 pathways results in up-regulation of the EDEM
family of proteins, which reduces the load of viral surface proteins,
possibly contributing to HBV persistence and chronicity. HBx induces
autophagosome formation via PI3KC3/Beclin-1 activation, which is
involved in HBV DNA replication. Transport of the V-ATPase to
autophagosomes is possibly impaired by HBx, resulting in elevated
vacuolar pH and lack of protein degradation.
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its promoter. This induces autophagy under nutrient starvation
conditions, which could be inhibited by Beclin-1 silencing with
specific siRNA. Intriguingly, Beclin-1 up-regulation was not con-
firmed in a subsequent study, despite HBx being also indicated
as the major factor triggering autophagy (Sir et al., 2010). Rather,
the process appeared to be mediated by activation of PI3KC3, an
enzyme playing a critical role autophagy initiation, following a
direct interaction with HBx.
Very recently, an independent study provided additional evi-
dence in support of the HBx role in the formation of autophago-
somes and a potential mechanism for the absence of protein
degradation observed, despite the activated autophagy (Liu et al.,
2014). It was shown that lysosomal activity was significantly per-
turbed in HBx-expressing cells, possibly due to mistrafficking of
the V-ATPase involved in lysosomes acidification. This results in
accumulation of defective lysosomes containing immature hydro-
lases, such as Cathepsin D, which are unable to degrade the cargo
proteins (Liu et al., 2014).
However, another series of experiments have implied that
S protein expression is sufficient to activate autophagy by a
mechanism involving cellular stress, excluding a potential con-
tribution of HBx (Li et al., 2011). High amounts of S protein
expressed either alone or in the context of the full viral replica-
tion resulted in phosphorylation of PERK and eIF2α, its direct
effector. Similarly, XBP1 mRNA splicing was induced by S, while
only the unspliced form could be detected in control cells, in the
absence of the viral protein. ATF6 activation was also investigated
in these cells; although the cleavage products could not be directly
evidenced, up-regulation of ATF6 downstream effectors, such as
GRP94 (Eletto et al., 2010) was unambiguously demonstrated.
Collectively, these data suggest that accumulation of the S protein
activates the ER stress pathways regulated by PERK, ATF6, and
IRE1. Moreover, knock-down of either signaling route efficiently
prevented LC3 lipidation and autophagosome formation induced
by the HBV surface protein, further supporting the hypothesis
above. Finally, an important fraction of the S protein associated
with the autophagosome membrane and a direct interaction with
LC3 was demonstrated, providing a potential mechanism for the
effects of the HBV-induced autophagy on the viral life-cycle (Li
et al., 2011).
These effects have raised additional controversy between the
two groups. One group suggested that autophagy is critical for
the viral DNA replication, while little effects were observed on
the RNA synthesis or its packaging into nucleocapsids (Sir et al.,
2010). Based on several lines of evidence, including: (a) the par-
tial co-localization of the HBV core and surface proteins with
LC3, (b) cell treatment with 3-MA, a PI3KC3 inhibitor, (c) spe-
cific down-regulation of Vps34, the catalytic subunit of PI3KC3
and of Atg7, an enzyme involved in autophagosomes formation, it
was proposed that early autophagic vacuolesmay function as plat-
forms for viral DNA replication and assembly. Alternatively, an
indirect role of the autophagosomes in HBV replication, by host-
ing signaling molecules involved in regulation of the core protein
phosphorylation is also likely. Important evidence for a role of
autophagy in the production HBV particles in vivo was provided
by the experiments using HBV transgenic mice with liver-specific
knockout of another autophagy initiating factor, Atg5 (Tian et al.,
2011). The impaired autophagy in this system resulted in a signif-
icant reduction of both, HBV DNA and SVP secretion in the mice
sera.
In contrast, the second group suggested that the UPR- induced
autophagy is required for efficient envelopment of the HBV
nucleocapsids, while the DNA replication is only moderately
affected. This conclusion was based on (a) the decreased secre-
tion of enveloped virions from cells treated with 3-MA, (b) the
increased amount of extracellular enveloped virions in the pres-
ence of autophagy inducers, such as rapamycin and starvation.
The lines of evidence provided by the two groups in support
of their conclusions appear compelling and difficult to reconcile
at a first glance. However, it is very likely that in fact, the two
mechanisms operate together, one or the other prevailing accord-
ing to the amount of viral protein expressed, or the hepatoma cell
line used, which may activate different levels of ER stress. It is
important to note, for instance, that the first study focused on
DNA replication in autophagy-inhibited cells, while the efficiency
of virion envelopment and secretion were not assessed (Sir et al.,
2010). Similarly, a moderate effect of the UPR-induced autophagy
on DNA replication was also observed in the second study, which
analyzed in more detail virion assembly and secretion (Li et al.,
2011). It would be interesting for future investigations to address
the relationship between the HBx and the envelope proteins in the
HBV-induced autophagy, in a more systematic manner and in the
context of a complete viral life-cycle, ideally in a natural infection
system.
Activation of the UPR and autophagy signaling during mild
ER stress clearly favors the recovery of the cellular homeostasis.
Asmentioned above, prolonged ER stress may trigger apoptosis to
remove the irreversibly damaged cells. This is a complex process
which relies on activation of transcription factors (e.g., the C/EPB
homologous protein -CHOP), phosphatases and kinases (e.g.,
the protein phosphatase 1—PP1, the apoptosis signal-regulating
kinase 1—ASK1, and JNK) (Nishitoh, 2012), which, in turn, reg-
ulate downstream pro-apoptotic factors (Wei et al., 2001). The
ability of HBV to induce apoptosis is a matter of intense debate,
which is far from being concluded. One set of experimental
data indicates the absence of apoptosis in HBV replicating cells
(Schulze-Bergkamen et al., 2003) or inhibition of apoptosis by
HBV, by several mechanisms (Huo et al., 2001; Marusawa et al.,
2003; Liu et al., 2013). In addition, it was recently shown that
artificially-induced apoptosis is detrimental to the HBV life-cycle
(Arzberger et al., 2010). In contrast, other reports suggest that
overexpression of the HBx protein can trigger apoptosis of liver
cells, in a p53-dependent (Wang et al., 2008) or -independent
manner (Terradillos et al., 1998). However, it remains to be estab-
lished whether expression of the HBx protein can reach this
critical levels in a natural infection and how the stage and pro-
gression of infection may influence the pro- or anti-apoptotic
responses observed in different HBV experimental systems.
CONCLUSION REMARKS
While the HBV-induced ER stress and UPR signaling have been
clearly established, the consequences of this activation on both,
the host cell and the virus life-cycle, are far from being elucidated.
There are many interesting issues that deserve deeper scrutiny,
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such as the relationship between the ER stress and carcinogene-
sis and the UPR modulation by HBV for own benefits, whether
this is protein folding, genome replication, virion assembly, or
establishment of chronic infection (Figure 3). It is important to
note that studies regarding the UPR at early stages of HBV infec-
tion have not even been addressed. This may be explained by the
difficulty to investigate HBV infection in vitro using the infec-
tivity models available. It is expected that the recent discoveries
of cellular factors facilitating HBV entry and the development
of new, improved cellular systems, permissive for HBV infection
(Yang et al., 2014), will help expand this research by approach-
ing the current controversies in the context of the whole viral
infection.
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